These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2568697)
1. Cardiovascular and pulmonary effects of beta-blocking agents: implications for their use in ophthalmology. Collignon P Surv Ophthalmol; 1989 Apr; 33 Suppl():455-6; discussion 459-60. PubMed ID: 2568697 [No Abstract] [Full Text] [Related]
2. Pharmacologic effects of beta-blocking agents used in the management of glaucoma. James IM Surv Ophthalmol; 1989 Apr; 33 Suppl():453-4; discussion 459-60. PubMed ID: 2568696 [No Abstract] [Full Text] [Related]
3. Cardiovascular effects of befunolol, betaxolol and timolol eye drops. Dorigo MT; Cerin O; Fracasso G; Altafini R Int J Clin Pharmacol Res; 1990; 10(3):163-6. PubMed ID: 1977708 [TBL] [Abstract][Full Text] [Related]
11. Changing therapy from timolol to betaxolol. Effect on intraocular pressure in selected patients with glaucoma. Timolol-Betaxolol Study Group. Vogel R; Tipping R; Kulaga SF; Clineschmidt CM Arch Ophthalmol; 1989 Sep; 107(9):1303-7. PubMed ID: 2571326 [TBL] [Abstract][Full Text] [Related]
12. Effects of topically applied falintolol: a new beta-adrenergic antagonist for treatment of glaucoma. Himber J; Sallee VL; Andermann G; Bouzoubaa M; Leclerc G; De Santis L J Ocul Pharmacol; 1987; 3(2):111-20. PubMed ID: 2903204 [TBL] [Abstract][Full Text] [Related]
13. Betaxolol and timolol. Harrison R Arch Ophthalmol; 1984 Oct; 102(10):1424, 1426. PubMed ID: 6148923 [No Abstract] [Full Text] [Related]
14. Comparison of the effect of timolol versus betaxolol ophthalmic on cardiopulmonary exercise performance in healthy volunteers. Dickstein K Surv Ophthalmol; 1989 Apr; 33 Suppl():457-8; discussion 459-60. PubMed ID: 2749518 [No Abstract] [Full Text] [Related]
15. Effects of timolol and latanoprost on respiratory and cardiovascular status in elderly patients with glaucoma. Ergin A; Ornek K; Güllü R; Bulcun E; Ekici M; Ekici A J Ocul Pharmacol Ther; 2009 Oct; 25(5):463-6. PubMed ID: 19552600 [TBL] [Abstract][Full Text] [Related]
16. Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis. Schoene RB; Abuan T; Ward RL; Beasley CH Am J Ophthalmol; 1984 Jan; 97(1):86-92. PubMed ID: 6141730 [TBL] [Abstract][Full Text] [Related]
17. Trimolol: effect on intraocular pressure in chronic open-angle glaucoma. Obstbaum SA; Galin MA; Katz IM Ann Ophthalmol; 1978 Oct; 10(10):1347-51. PubMed ID: 31126 [TBL] [Abstract][Full Text] [Related]
18. Betaxolol. A new beta-adrenergic blocking agent for treatment of glaucoma. Berrospi AR; Leibowitz HM Arch Ophthalmol; 1982 Jun; 100(6):943-6. PubMed ID: 6124227 [TBL] [Abstract][Full Text] [Related]
19. Retrobulbar arterial hemodynamic effects of betaxolol and timolol in normal-tension glaucoma. Harris A; Spaeth GL; Sergott RC; Katz LJ; Cantor LB; Martin BJ Am J Ophthalmol; 1995 Aug; 120(2):168-75. PubMed ID: 7639300 [TBL] [Abstract][Full Text] [Related]
20. ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects. Nathanson JA Br J Pharmacol; 1984 Nov; 83(3):821-9. PubMed ID: 6150744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]